Evidence map›Paper›PMID 36142821›Full record

ArticleInternational journal of molecular sciences2022

A Novel Approach of SWATH-Based Metabolomics Analysis Using the Human Metabolome Database Spectral Library.

Hassan Shikshaky, Eman Abdelnaby Ahmed, Ali Mostafa Anwar, Aya Osama, Shahd Ezzeldin, Antony Nasr, Sebaey Mahgoub, Sameh Magdeldin

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Unveiling Microbial Chemical Interactions Based on Metabolomics Approaches.Advances in experimental medicine and biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hassan ShikshakyProteomics and Metabolomics Research Program, Basic Research Department, Children's Cancer Hospital Egypt 57357, Cairo 11441, Egypt.ORCID 0000-0002-2948-9845
Eman Abdelnaby AhmedProteomics and Metabolomics Research Program, Basic Research Department, Children's Cancer Hospital Egypt 57357, Cairo 11441, Egypt.ORCID 0000-0003-0973-2630
Ali Mostafa AnwarProteomics and Metabolomics Research Program, Basic Research Department, Children's Cancer Hospital Egypt 57357, Cairo 11441, Egypt.
Aya OsamaProteomics and Metabolomics Research Program, Basic Research Department, Children's Cancer Hospital Egypt 57357, Cairo 11441, Egypt.
Shahd EzzeldinProteomics and Metabolomics Research Program, Basic Research Department, Children's Cancer Hospital Egypt 57357, Cairo 11441, Egypt.
Antony NasrProteomics and Metabolomics Research Program, Basic Research Department, Children's Cancer Hospital Egypt 57357, Cairo 11441, Egypt.
Sebaey MahgoubProteomics and Metabolomics Research Program, Basic Research Department, Children's Cancer Hospital Egypt 57357, Cairo 11441, Egypt.ORCID 0000-0001-9711-6242
Sameh MagdeldinProteomics and Metabolomics Research Program, Basic Research Department, Children's Cancer Hospital Egypt 57357, Cairo 11441, Egypt.ORCID 0000-0002-7507-9935

Funding

This work was supported by the Egyptian Cancer Network, USA (ECN) and the Children's Cancer Hospital Egypt 57357. internal support
6 · The paper itself

Abstract

Metabolomics is a potential approach to paving new avenues for clinical diagnosis, molecular medicine, and therapeutic drug monitoring and development. The conventional metabolomics analysis pipeline depends on the data-independent acquisition (DIA) technique. Although powerful, it still suffers from stochastic, non-reproducible ion selection across samples. Despite the presence of different metabolomics workbenches, metabolite identification remains a tedious and time-consuming task. Consequently, sequential windowed acquisition of all theoretical MS (SWATH) acquisition has attracted much attention to overcome this limitation. This article aims to develop a novel SWATH platform for data analysis with a generation of an accurate mass spectral library for metabolite identification using SWATH acquisition. The workflow was validated using inclusion/exclusion compound lists. The false-positive identification was 3.4% from the non-endogenous drugs with 96.6% specificity. The workflow has proven to overcome background noise despite the complexity of the SWATH sample. From the Human Metabolome Database (HMDB), 1282 compounds were tested in various biological samples to demonstrate the feasibility of the workflow. The current study identified 377 compounds in positive and 303 in negative modes with 392 unique non-redundant metabolites. Finally, a free software tool, SASA, was developed to analyze SWATH-acquired samples using the proposed pipeline.

Indexed as

MetabolomeMetabolomicsDatabases, FactualHumansSoftwareWorkflowdata-independent acquisitionhigh-resolution LC-MSmetabolomicsMS/MS librarySWATH

Identifiers

PMID36142821
PMCPMC9500730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.